Jon Ruckle

Single-Dose, Randomized, Double-Blind, Placebo-Controlled Study of ACE-011 (ActRIIA-IgG1) in Postmenopausal Women

Jon Ruckle, Mark Jacobs, William G. Kramer et al. · Journal of Bone and Mineral Research · 2008 · 208 citations

Medicine, Pharmacokinetics, Pharmacology +15

BPS804 Anti-Sclerostin Antibody in Adults With Moderate Osteogenesis Imperfecta: Results of a Randomized Phase 2a Trial

Francis H. Glorieux, Jean‐Pierre Devogelaer, Michaela Durigova et al. · Journal of Bone and Mineral Research · 2017 · 143 citations · Full text

Medicine, Immunology, Pharmacotherapy +16

Safety and Pharmacokinetics of Single Doses of (+)-Calanolide A, a Novel, Naturally Occurring Nonnucleoside Reverse Transcriptase Inhibitor, in Healthy, Human Immunodeficiency Virus-Negative Human Subjects

Terri Creagh, Jon Ruckle, Dwain T. Tolbert et al. · Antimicrobial Agents and Chemotherapy · 2001 · 95 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Lycopene bioavailability and metabolism in humans: an accelerator mass spectrometry study

Alastair B. Ross, Le T. Vuong, Jon Ruckle et al. · American Journal of Clinical Nutrition · 2011 · 89 citations · Full text

Life Sciences, Nutritional Sciences, Pharmacokinetics +12

Safety and Pharmacokinetics of the Anti-Orthopoxvirus Compound ST-246 following a Single Daily Oral Dose for 14 Days in Human Volunteers

Jarasvech Chinsangaram, Kady M. Honeychurch, Shanthakumar Tyavanagimatt et al. · Antimicrobial Agents and Chemotherapy · 2012 · 52 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +12